Safety of combined pharmacotherapy.
O'Malley
K D
KD
D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000316:Adrenergic alpha-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002665:Child Psychiatry / Q000379:methods; D003000:Clonidine / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D004347:Drug Interactions; D063647:Fetal Alcohol Spectrum Disorders / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use
D018759:Adrenergic Uptake Inhibitors; D000316:Adrenergic alpha-Agonists; D008774:Methylphenidate; D003000:Clonidine